No definition available.
Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
C3_TESTIS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
720 |
4. Check minimum number of eventsNone |
720 |
5. Include endpointsNone |
720 |
6. Filter based on genotype QC (FinnGen only) |
720 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 720 | - | 720 |
| Unadjusted period prevalence (%) | 0.32 | - | 0.32 |
| Median age at first event (years) | 37.17 | - | 37.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 566
- Matched controls
- 5659
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
725.5
323.0
333
11
KFC00
NOMESCO Finland
Unilateral orchiectomy
1256.7
323.0
404
11
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
268.8
236
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
245.1
217
*
130
Kela drug reimbursment
Malignant tumour
+∞
197.8
178
*
JN4BD
NOMESCO Finland
Extensive body CT
36.8
176.3
231
104
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
160.2
146
*
A03FA01
ATC
metoclopramide; systemic, rectal
17.6
130.1
220
197
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1298.2
112.5
106
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
98.9
92
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.6
98.3
158
115
A04AA02
ATC
granisetron; systemic, transdermal
+∞
88.9
83
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
88.9
83
*
JN4AD
NOMESCO Finland
Body CT examination
22.6
84.2
125
70
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
282.9
74.3
74
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
73.5
69
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
70.3
66
*
H02AB02
ATC
dexamethasone; systemic
58.8
69.4
81
16
L03AA02
ATC
filgrastim; parenteral
252.5
66.7
67
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
63.3
334
1344
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
62.7
59
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
60.5
57
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
629.5
58.8
57
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
54.0
51
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
532.2
50.2
49
*
A04AA01
ATC
ondansetron; systemic, rectal
35.9
49.8
64
20
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
49.7
47
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
48.6
46
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
47.8
242
866
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
39.0
37
*
JN3AD
NOMESCO Finland
Abdominal CT examination
7.5
38.4
96
150
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.2
38.3
111
213
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
37.9
36
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
37.9
36
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.3
37.5
50
18
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
36.9
35
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
104.5
36.2
39
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
35.8
34
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
35.8
34
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
35.8
34
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
33.7
32
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
33.7
32
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
33.7
32
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.6
31
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
341.7
32.2
32
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
31.5
30
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
330.0
31.1
31
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
23.8
29.6
42
19
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.4
28
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
29.4
28
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
29.4
181
704
D70.82
ICD-10 Finland
Drug-induced neutropenia
51.5
28.7
34
7
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
28.4
27
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
28.4
27
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
27.3
26
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
26.2
25
*
WF002
NOMESCO Finland
Radical radiotherapy
260.9
24.9
25
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
24.1
23
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
24.1
106
309
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
23.1
22
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
23.1
22
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.4
21.0
31
16
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
21.0
20
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
21.0
20
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.9
20.5
91
266
N02BE01
ATC
paracetamol; systemic, rectal
2.6
20.3
459
3502
N02AA05
ATC
oxycodone; systemic
4.2
19.7
80
215
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
206.8
19.7
20
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
47.8
19.3
23
5
WZC30
NOMESCO Finland
Teaching
3.8
18.1
80
232
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.9
17.8
51
94
Y78
ICPC
Malign neopl male genital other
+∞
17.8
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.8
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.6
17.8
53
103
WX320
NOMESCO Finland
Spinalanesthesy
2.8
17.7
128
531
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
17.5
72
196
L01BC06
ATC
capecitabine; oral
+∞
16.7
16
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.7
16
*
WW500
NOMESCO Finland
Blood transfusion
12.1
16.7
30
26
WX402
NOMESCO Finland
General anaesthesia
3.1
16.3
100
371
DFF00
NOMESCO Finland
Pure tone audiometry
4.1
16.1
65
174
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
15.7
15
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
15.7
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
164.2
15.5
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.9
14.9
37
57
Y05
ICPC
Scrotum/testis sympt/compl other
10.1
14.9
29
30
E29.1
ICD-10 Finland
Testicular hypofunction
6.5
14.7
38
62
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
14.6
14
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
14.6
14
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.2
14.1
34
50
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
13.6
13
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
13.6
13
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
ZX120
NOMESCO Finland
Intravenous
3.7
13.1
58
168
B01AB10
ATC
tinzaparin; parenteral
5.5
13.0
38
73
Z51.5
ICD-10 Finland
Palliative care
11.9
12.9
23
20
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
51.2
12.9
15
*
B01AB05
ATC
enoxaparin; parenteral
2.3
12.8
133
661
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.5
12
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
132.7
12.5
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
12.1
46
117
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.7
11.9
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
66.3
11.6
13
*
A02BC02
ATC
pantoprazole; systemic
1.9
11.6
300
2136
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
11.5
11
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
+∞
11.5
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
R50.9
ICD-10 Finland
Fever, unspecified
2.7
11.4
86
358
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
11.3
94
415
KF8AE
SPAT
NA
9.5
11.1
22
24
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
44.2
11.0
13
*
KFA00
NOMESCO Finland
Exploration of testis
10.9
10.8
20
19
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
10.5
79
331
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.9
10.0
24
36
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
9.0
9.8
20
23
N05BA06
ATC
lorazepam; systemic, sublingual
3.9
9.5
38
102
JN6AD
NOMESCO Finland
CT of torso and neck
30.6
9.4
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.1
9.1
24
41
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.9
105
546
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.5
8.9
22
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
8.9
22
35
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
50.8
8.7
10
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
50.8
8.7
10
*
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
11.8
8.6
15
13
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.9
8.4
20
30
N46
ICD-10 Finland
Male infertility
3.7
8.4
36
103
L02BB03
ATC
bicalutamide; oral
+∞
8.3
8
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
8.3
8
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.2
198
1332
7513
FHL
Test prosthesis installation
17.5
8.1
12
7
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
7.9
7.9
17
22
ZXA05
NOMESCO Finland
Left side
1.9
7.6
111
631
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
7.5
84
427
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
7.5
30
82
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
81.1
7.4
8
*
KA1FN
NOMESCO Finland
Isotope renography
13.6
7.4
12
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
7.3
36
116
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
KFB00
NOMESCO Finland
Biopsy of testis
16.0
7.2
11
7
M04AA01
ATC
allopurinol; systemic
2.3
7.2
69
328
J01MA12
ATC
levofloxacin; systemic
2.1
7.1
84
438
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.9
7.1
14
16
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
6.9
31
94
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.7
81
425
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
6.6
50
212
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
70.6
6.4
7
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
70.6
6.4
7
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
14.5
6.4
10
7
Y28
ICPC
Limited function/disability (Y)
9.4
6.3
12
13
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
27.0
6.2
8
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.2
6.0
11
11
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.6
6.0
16
29
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.0
79
427
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
177
14
167.31
307.65
10.2
1.3
—
—
—
0
0
151
91
20.73
186.49
3.2
1.5
15.9
6.8
iu/l
6.49
122
72
196
224
11.65
165.03
2.9
1.6
7.4
4.1
u/l
7.14
165
188
297
873
5.09
96.68
4.1
2.4
13.4
15.3
nmol/l
4.40
283
800
481
2284
4.33
78.03
10.3
4.5
10.7
13.3
umol/l
6.13
476
2169
578
3692
3.87
49.13
12.6
5.9
78.7
75.1
u/l
0.93
568
3473
468
2746
3.01
43.53
13.2
8.3
3.6
4.2
e9/l
6.83
427
2399
276
1246
2.97
41.42
5.3
2.0
2.4
2.4
mmol/l
0.60
248
1073
69
133
5.63
34.75
1.7
3.1
169.7
187.2
%
0.80
69
128
170
646
3.14
33.80
5.7
2.0
2.4
2.4
mmol/l
1.11
151
549
264
1297
2.63
32.17
3.5
2.8
56.9
105.1
e6/l
0.34
207
1003
243
1173
2.62
30.41
3.3
2.8
0.4
0.3
e6/l
0.21
190
874
418
2590
2.46
30.39
4.1
3.1
4.2
314.7
e6/l
—
5
38
325
1826
2.42
29.04
4.5
3.7
—
—
—
0
0
328
1869
2.39
28.17
9.4
4.5
36.2
36.8
g/l
0.79
306
1727
288
1576
2.38
26.83
3.6
2.9
—
—
—
0
0
72
185
4.21
25.61
5.5
2.0
4.2
4.2
ug/l
0.00
57
147
425
2801
2.26
24.79
6.0
4.8
6.6
6.8
mmol/l
0.80
409
2649
343
2099
2.21
23.70
10.5
6.2
1.2
1.2
mmol/l
0.51
270
1789
156
680
2.65
23.32
3.2
2.7
0.4
0.6
e6/l
0.50
96
367
158
717
2.54
21.60
3.0
2.5
0.9
0.9
e6/l
0.08
98
405
310
1886
2.13
21.07
9.0
5.8
1.2
1.2
mmol/l
0.45
299
1706
223
1290
2.06
16.52
3.5
2.4
6807.2
6635.5
umol/l
0.01
207
1157
177
987
2.05
14.22
1.8
1.8
1.3
1.0
mg/l
0.85
135
703
599
5003
2.17
13.75
20.4
9.9
89.5
88.4
ml/min/173m2
0.48
537
4071
17
5
34.76
13.55
1.2
1.0
—
—
—
0
0
31
68
4.72
13.41
1.9
1.8
—
—
—
0
0
166
941
1.99
12.58
2.9
2.3
—
—
—
0
0
16
19
8.59
12.41
3.5
1.1
187.6
194.8
u/l
0.15
16
19
620
5321
2.19
12.12
22.7
13.1
139.4
139.7
mmol/l
2.91
609
5165
620
5346
2.15
11.57
23.2
13.2
4.0
4.0
mmol/l
0.67
608
5186
35
96
3.78
11.36
2.0
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
126
3.39
11.25
3.7
2.9
0.3
0.3
u/ml
0.32
21
66
35
99
3.66
10.87
2.0
1.7
—
—
—
0
0
129
707
2.00
10.62
2.5
1.8
—
—
—
0
0
91
445
2.20
10.10
3.9
2.9
—
—
—
0
0
613
5345
1.99
9.85
21.1
11.2
23.8
24.9
mg/l
0.36
518
4074
31
87
3.68
9.75
2.7
4.1
58.3
56.3
%
0.51
31
87
36
112
3.33
9.70
7.3
5.7
861.5
608.4
iu/ml
—
6
14
30
85
3.64
9.31
2.7
4.0
4.0
4.3
e9/l
0.26
30
85
27
79
3.51
8.01
2.6
3.0
—
478.1
—
0
9
64
301
2.24
7.80
2.2
1.6
—
—
—
0
0
523
4471
1.62
7.54
27.2
13.6
13.5
13.4
%
2.14
515
4356
115
677
1.83
7.51
3.4
2.4
12.7
14.4
umol/l
1.56
107
622
92
509
1.93
7.28
2.5
1.7
—
—
—
0
0
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
16
35
4.65
6.96
2.0
1.7
0.1
0.1
nmol/l
0.11
16
27
19
48
4.04
6.93
1.7
2.1
—
—
—
0
0
283
2143
1.53
6.83
3.1
2.9
0.0
0.0
estimate
0.49
72
359
281
2133
1.52
6.66
4.6
4.0
0.0
0.0
estimate
0.00
73
378
57
279
2.13
6.32
1.6
1.4
—
—
—
0
0
98
579
1.80
6.30
3.8
2.4
23.6
25.8
%
0.91
85
498
17
43
4.02
6.19
2.1
1.6
—
—
—
0
0
103
622
1.77
6.15
3.6
2.4
2.2
2.3
g/l
0.21
97
571
639
5848
1.82
6.13
14.9
8.2
32.0
33.6
u/l
1.26
634
5656
89
519
1.82
5.97
2.5
1.8
—
—
—
0
0
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
280
2163
1.48
5.93
3.2
2.9
0.0
0.0
estimate
0.00
67
345
16
40
4.07
5.92
2.2
1.6
—
—
—
0
0
78
445
1.84
5.62
3.4
2.4
31.2
143.3
u/l
0.55
64
389
20
62
3.29
5.48
1.5
1.7
—
—
—
0
0
8
5
16.16
5.42
1.0
1.0
—
—
—
0
0
24
85
2.89
5.29
1.3
1.3
—
—
—
0
0
25
93
2.75
5.05
1.6
1.5
276.4
310.2
ug/g
0.26
15
54
86
522
1.74
5.04
5.9
2.6
11.9
10.0
umol/l
0.19
77
463
80
476
1.77
5.03
5.2
3.4
1.6
1.9
mmol/l
0.39
65
385
80
479
1.75
4.92
5.2
3.4
5.8
6.0
kpa
0.70
80
464
17
51
3.39
4.91
1.1
1.2
—
—
—
0
0
24
89
2.76
4.89
1.3
1.7
—
—
—
0
0
352
2924
1.40
4.69
4.3
3.3
2.4
1.7
ug/l
0.61
311
2650
195
1460
1.46
4.64
3.4
2.6
54.0
58.7
u/l
1.40
181
1371
50
270
1.92
4.29
2.0
1.6
—
—
—
0
0
11
27
4.12
4.17
1.3
2.1
—
—
—
0
0
220
1717
1.41
4.10
3.3
3.0
—
—
—
0
0
43
224
1.98
4.10
3.8
2.4
0.1
0.2
e6/l
0.91
43
218
21
85
2.51
3.66
1.5
1.6
—
—
—
0
0
17
62
2.78
3.61
1.5
1.5
—
—
—
0
0
60
366
1.70
3.50
2.6
2.2
68.3
69.4
ml/min/173m2
0.05
22
139
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
502
5440
0.75
3.18
4.1
4.0
1.2
1.3
mmol/l
1.94
469
5109
52
315
1.70
3.13
3.9
3.1
1.3
1.7
mmol/l
0.36
39
223
21
92
2.32
3.13
3.1
2.4
130.9
137.7
g/l
0.38
13
67
514
5545
0.74
3.09
4.4
4.4
2.8
2.8
mmol/l
0.09
485
5203
31
160
1.98
3.09
2.9
1.7
—
—
—
0
0
25
119
2.14
3.07
1.4
1.6
—
—
—
0
0
17
68
2.54
3.06
1.5
1.5
—
—
—
0
0
79
536
1.53
3.01
10.9
8.8
0.8
1.1
mmol/l
0.49
64
417
131
982
1.41
3.01
2.6
2.1
3.1
2.8
mg/l
0.52
114
825
40
230
1.78
2.89
4.7
3.0
23.9
25.2
mmol/l
1.59
40
221
22
102
2.19
2.89
1.4
1.3
—
—
—
0
0
22
102
2.19
2.89
1.4
1.3
—
—
—
0
0
52
326
1.64
2.77
3.6
2.7
125.4
136.9
g/l
2.22
52
318
5
6
8.38
2.75
1.0
3.0
—
—
—
0
0
17
72
2.39
2.74
1.1
1.6
—
—
—
0
0
43
258
1.71
2.70
1.4
1.4
—
—
—
0
0
78
541
1.50
2.70
10.9
8.7
5.2
5.1
kpa
0.05
73
514
212
1740
1.31
2.70
4.7
3.1
36.6
38.2
u/l
0.15
204
1647
13
49
2.68
2.63
1.2
1.1
—
—
—
0
0
156
1231
1.34
2.60
3.2
3.2
1317.1
1495.0
ng/l
0.25
134
1028
11
38
2.92
2.59
3.5
2.4
—
—
—
0
0
510
5470
0.77
2.59
4.1
4.0
4.6
4.6
mmol/l
0.10
479
5154
9
25
3.63
2.58
1.2
1.7
—
—
—
0
0
12
44
2.76
2.55
2.1
2.1
—
—
—
0
0
5
7
7.18
2.55
1.0
1.1
—
—
—
0
0
65
442
1.52
2.48
12.4
9.9
119.3
128.6
g/l
2.74
65
424
60
401
1.54
2.48
4.8
2.7
5.2
4.7
kpa
1.06
60
386
7
16
4.41
2.48
8.7
1.9
—
—
—
0
0
15
63
2.41
2.47
1.1
1.1
—
—
—
0
0
8
21
3.84
2.47
1.3
1.8
—
—
—
0
0
8
21
3.84
2.47
1.3
1.8
—
—
—
0
0
33
189
1.78
2.45
6.5
6.7
1.7
1.7
%
0.01
33
177
62
424
1.51
2.32
2.5
1.8
367.9
363.2
nmol/l
0.08
56
390
224
1885
1.27
2.30
4.0
3.5
54.2
52.5
ng/l
0.03
168
1242
26
143
1.85
2.21
2.4
1.5
—
—
—
0
0
392
3533
1.24
2.17
4.0
3.7
11.9
8.9
mm/h
3.11
365
3280
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
27
152
1.81
2.15
1.1
1.2
—
—
—
0
0
12
49
2.47
2.11
3.2
3.9
—
—
—
0
0
493
5268
0.80
2.10
3.7
3.6
1.5
1.4
mmol/l
0.99
458
4941
196
1643
1.27
2.06
2.6
2.4
0.7
0.7
ug/l
0.41
123
932
19
97
1.98
2.02
1.5
1.2
—
—
—
0
0
5
11
4.57
1.94
1.8
3.5
—
—
—
0
0
8
27
2.98
1.94
2.6
2.0
—
—
—
0
0
36
229
1.60
1.88
5.8
3.3
53.9
51.6
%
0.21
36
224
9
34
2.67
1.87
1.2
1.6
—
—
—
0
0
22
123
1.81
1.82
1.3
1.3
64.9
71.3
pmol/l
0.11
16
30
11
47
2.36
1.78
1.1
1.0
—
—
—
0
0
11
47
2.36
1.78
1.3
1.1
—
—
—
0
0
7
24
2.93
1.72
1.1
1.1
—
—
—
0
0
5
13
3.86
1.71
3.6
1.8
—
—
—
0
0
30
187
1.63
1.71
2.2
3.2
5.1
4.8
pmol/l
0.50
25
170
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
25
149
1.70
1.69
1.1
1.2
274.9
268.7
u/ml
0.04
17
88
11
49
2.26
1.64
1.8
1.2
—
—
—
0
0
11
49
2.26
1.64
1.8
1.2
—
—
—
0
0
17
91
1.89
1.61
4.0
2.6
16.8
17.2
%
0.12
12
52
15
77
1.97
1.60
2.3
1.3
3.8
8.4
u/ml
—
6
26
454
4841
0.83
1.59
5.7
5.2
39.8
39.6
mmol/mol
0.14
417
4558
98
778
1.30
1.59
1.9
1.7
1074.1
1164.3
nmol/l
0.50
72
607
18
99
1.84
1.58
1.8
1.3
56.0
47.5
mg/l
0.24
13
77
20
114
1.78
1.58
1.4
1.2
—
—
—
0
0
18
100
1.82
1.54
1.9
1.3
44.3
36.3
mg/l
0.24
13
79
14
73
1.94
1.44
2.4
1.3
6.3
7.0
u/ml
—
8
40
476
5034
0.84
1.42
4.2
3.9
6.0
6.0
mmol/l
0.16
433
4631
21
128
1.66
1.34
6.0
2.3
24.9
24.4
mmol/l
0.20
21
112
16
90
1.80
1.34
1.1
1.8
—
—
—
0
0
20
315
0.62
1.27
1.3
1.7
—
—
—
0
0
553
5292
1.19
1.22
24.0
11.7
40.8
42.6
%
4.46
439
4149
68
538
1.29
1.17
3.8
4.3
28.3
29.6
%
0.42
52
383
198
1755
1.18
1.15
1.9
1.8
90.8
94.0
pmol/l
0.44
113
987
24
160
1.52
1.10
2.2
3.7
—
—
—
0
0
7
31
2.27
1.10
1.9
2.5
—
—
—
0
0
46
600
0.75
1.09
1.2
1.2
3.3
8.1
u/ml
0.99
12
252
132
1135
1.20
1.09
3.4
3.2
0.0
0.0
estimate
0.25
69
353
99
830
1.22
1.06
1.8
2.2
—
—
—
0
0
7
33
2.13
1.05
1.3
1.0
—
—
—
0
0
9
46
1.97
1.04
1.1
1.2
—
—
—
0
0
37
273
1.37
1.03
7.1
4.4
125.7
95.6
ng/l
1.01
30
244
27
188
1.45
1.03
2.5
2.4
230.5
592.7
ug/l
0.88
27
183
253
2315
1.14
0.95
3.5
3.2
21.1
23.8
%
1.58
101
883
56
691
0.79
0.90
1.2
1.2
15.0
23.6
iu/ml
1.65
17
201
8
42
1.91
0.88
1.6
1.4
1.2
1.0
g/l
—
8
42
89
755
1.20
0.87
1.8
2.2
—
—
—
0
0
12
73
1.65
0.82
1.2
1.1
—
—
—
0
0
91
1057
0.84
0.81
1.3
1.2
4.7
1.6
u/ml
0.49
23
313
13
81
1.62
0.81
1.2
1.1
—
—
—
0
0
195
1776
1.13
0.78
3.7
2.5
207.6
173.4
ug/l
1.13
178
1643
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
108
950
1.16
0.71
4.1
3.5
504.3
857.7
ng/l
0.78
84
712
5
26
1.93
0.70
2.0
2.1
—
—
—
0
0
22
161
1.38
0.69
1.7
1.8
—
—
—
0
0
25
329
0.75
0.69
2.6
2.4
31.8
16.0
au/ml
—
5
27
7
42
1.67
0.68
1.0
1.4
—
—
—
0
0
21
153
1.38
0.67
1.2
1.1
—
—
—
0
0
5
28
1.79
0.66
3.0
1.1
—
—
—
0
0
18
128
1.42
0.66
1.1
1.2
568.0
541.1
mg/l
0.18
18
120
21
155
1.37
0.63
1.2
1.1
—
—
—
0
0
15
104
1.45
0.63
1.2
1.2
3.7
3.8
mmol/l
0.28
15
95
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
106
946
1.14
0.59
1.5
1.5
18.4
19.2
nmol/l
0.25
94
812
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
6
36
1.67
0.56
1.7
1.7
—
2294428.6
—
0
7
9
60
1.51
0.54
1.1
1.0
—
—
—
0
0
6
38
1.58
0.54
1.7
1.1
—
—
—
0
0
95
1061
0.88
0.54
1.8
2.0
1.5
1.5
%
0.01
90
958
9
64
1.41
0.51
1.9
2.0
20.9
21.5
nmol/l
—
9
59
18
135
1.34
0.51
1.2
1.6
—
—
—
0
0
154
1666
0.90
0.51
3.1
3.8
9.3
9.1
mmol/l
0.15
123
1423
7
48
1.46
0.47
1.0
1.3
—
—
—
0
0
63
715
0.87
0.47
1.7
1.7
—
—
—
0
0
7
49
1.43
0.46
1.0
1.1
272.9
284.2
mg/l
—
7
40
7
51
1.38
0.44
1.1
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
5
34
1.47
0.40
1.0
1.0
1438.8
1600.9
miu/ml
—
5
34
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
353
3411
1.07
0.38
3.2
2.8
14.9
14.9
pmol/l
0.03
316
3093
30
255
1.18
0.35
1.3
1.2
—
—
—
0
0
7
53
1.32
0.31
1.1
1.0
—
—
—
0
0
27
232
1.17
0.29
3.2
2.8
—
—
—
0
0
23
196
1.18
0.27
3.3
2.8
—
—
—
0
0
151
1437
1.06
0.26
2.5
2.2
180.4
351.5
u/l
1.39
146
1355
16
132
1.22
0.26
2.0
2.0
—
—
—
0
0
97
1033
0.93
0.25
3.1
3.4
1.0
1.0
kg/l
0.06
15
127
18
152
1.19
0.24
1.1
1.3
—
—
—
0
0
28
248
1.13
0.22
2.2
2.2
41.4
39.4
u/l
0.15
23
224
412
4043
1.04
0.22
3.7
3.1
62.5
49.3
u/l
1.44
395
3836
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
173.7
—
0
7
17
147
1.16
0.18
1.9
2.4
11.5
10.3
mg/l
0.23
17
138
7
59
1.19
0.18
1.1
1.0
242.6
266.0
mg/l
—
7
53
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
103
1069
0.96
0.13
1.5
1.4
—
—
—
0
0
19
211
0.90
0.13
1.4
1.7
—
230.0
—
0
6
444
4397
1.03
0.11
3.8
3.4
1.8
2.2
mu/l
0.64
400
4024
15
166
0.90
0.10
1.1
1.3
215.3
171.6
miu/ml
—
8
69
145
1481
0.97
0.08
4.0
4.3
10.3
10.7
mg/mmol
0.04
92
1017
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
14
154
0.91
0.08
1.9
2.4
67.9
117.9
ug/min
—
9
90
14
128
1.10
0.06
1.6
1.3
—
—
—
0
0
11
99
1.11
0.06
1.2
1.1
—
—
—
0
0
12
130
0.92
0.04
5.1
1.4
1.3
1.2
g/l
0.49
12
124
60
612
0.98
0.03
32.7
24.3
1.3
1.3
inr
—
10
83
24
231
1.04
0.03
1.0
1.1
—
—
—
0
0
12
128
0.94
0.02
5.1
1.3
0.3
0.2
g/l
0.39
12
122
131
1320
0.99
0.01
1.8
1.7
1.6
1.5
mmol/l
0.16
107
1126
93
921
1.01
0.01
1.7
1.7
423.6
52692720.7
pmol/l
1.46
75
780
15
144
1.04
0.00
1.0
1.1
—
—
—
0
0
400
4007
1.00
0.00
2.9
3.0
—
—
—
0
0
30
306
0.98
0.00
9.1
8.4
24.2
24.2
mmol/l
0.01
30
285
14
136
1.03
0.00
1.1
1.3
—
—
—
0
0
57
575
0.99
0.00
9.0
6.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
9
96
0.94
0.00
1.0
1.3
45.4
16.2
u/l
—
9
85
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
172
1720
1.00
0.00
2.6
2.3
71.6
71.4
nmol/l
0.02
155
1567
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
1.7
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
3.2
—
0
6
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.3
—
85.6
—
0
9
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.2
1.2
9039.0
66433.2
e6/l
—
5
40
8
81
0.99
0.00
1.5
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
2.0
6.3
—
—
—
0
0
5
59
0.85
0.00
1.4
2.0
—
—
—
0
0
7
79
0.88
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_EXALLC – Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)
GWS hits: 3
This endpoint is excluded (different definition than used in FinnGen).